Search - tctmd.com

Displaying 621 - 640 of 676

Sort: Relevancy | Date

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

Presenter: Yu Taniguchi

October 29, 2013

News Conference News TCT 2013

Transradial Approach Just as Safe, Effective as Transfemoral for Carotid Artery Stenting

October 29, 2013

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

Presentation TCT 2013

Autonomic Regulation of the Cardiovascular System in Hypertension and Heart Failure: State-of-the-Art

Presenter: Paul Sobotka

October 28, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Presentation TCT 2013

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Presenter: Alex Rothman

October 28, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Changing Vessel Compliance to Treat Hypertension (Rox Medical)

Presenter: David Deaton

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

Presentation TCT 2013

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Presenter: David Kandzari

October 27, 2013

Presentation TCT 2013

Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology?

Presenter: Robert Whitbourn

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Presenter: Jan Pietzsch

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness Considerations for Mild and Moderate Hypertension

Presenter: Mark Hlatky

October 27, 2013

Presentation TCT 2013

Case Presentation: Hypertension Therapies and Renal Denervation

Presenter: Ajay Kirtane

October 27, 2013

Presentation TCT 2013

ASD and Pulmonary Hypertension: Implications for Closure

Presenter: Robert Sommer

October 27, 2013

Advertisement

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

Transradial Approach Just as Safe, Effective as Transfemoral for Carotid Artery Stenting

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Autonomic Regulation of the Cardiovascular System in Hypertension and Heart Failure: State-of-the-Art

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Changing Vessel Compliance to Treat Hypertension (Rox Medical)

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Preliminary Data Show Potential of Renal Denervation in Several Settings

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Is the Noncompliant Patient with Severe Treatment Resistant Hypertension an Appropriate Candidate for this Technology?

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Cost-Effectiveness Considerations for Mild and Moderate Hypertension

Case Presentation: Hypertension Therapies and Renal Denervation

ASD and Pulmonary Hypertension: Implications for Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content